197 related articles for article (PubMed ID: 3920634)
1. Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity.
Hudson AT; Randall AW; Fry M; Ginger CD; Hill B; Latter VS; McHardy N; Williams RB
Parasitology; 1985 Feb; 90 ( Pt 1)():45-55. PubMed ID: 3920634
[TBL] [Abstract][Full Text] [Related]
2. Antitheilerial activity of BW720C (buparvaquone): a comparison with parvaquone.
McHardy N; Wekesa LS; Hudson AT; Randall AW
Res Vet Sci; 1985 Jul; 39(1):29-33. PubMed ID: 3929346
[TBL] [Abstract][Full Text] [Related]
3. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.
Darkin-Rattray SJ; Gurnett AM; Myers RW; Dulski PM; Crumley TM; Allocco JJ; Cannova C; Meinke PT; Colletti SL; Bednarek MA; Singh SB; Goetz MA; Dombrowski AW; Polishook JD; Schmatz DM
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13143-7. PubMed ID: 8917558
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum.
Baramee A; Coppin A; Mortuaire M; Pelinski L; Tomavo S; Brocard J
Bioorg Med Chem; 2006 Mar; 14(5):1294-302. PubMed ID: 16242338
[TBL] [Abstract][Full Text] [Related]
5. Activity of buparvaquone against Theileria cervi in white-tailed deer.
Mitema ES; Kocan AA; Mukolwe SW; Sangiah S; Sherban D
Vet Parasitol; 1991 Jan; 38(1):49-53. PubMed ID: 1902608
[TBL] [Abstract][Full Text] [Related]
6. Antiparasitic agent atovaquone.
Baggish AL; Hill DR
Antimicrob Agents Chemother; 2002 May; 46(5):1163-73. PubMed ID: 11959541
[No Abstract] [Full Text] [Related]
7. In vitro activity of 2-alkyl-3-hydroxy-1,4-naphthoquinones against Theileria parva.
Boehm P; Cooper K; Hudson AT; Elphick JP; McHardy N
J Med Chem; 1981 Mar; 24(3):295-9. PubMed ID: 6790703
[TBL] [Abstract][Full Text] [Related]
8. The apicoplast as a potential therapeutic target in and other apicomplexan parasites.
Soldati D
Parasitol Today; 1999 Jan; 15(1):5-7. PubMed ID: 10234168
[No Abstract] [Full Text] [Related]
9. The chemotherapy of protozoal infections of man.
Steck EA
J Protozool; 1981 Feb; 28(1):10-6. PubMed ID: 6788942
[No Abstract] [Full Text] [Related]
10. The apicoplast as a potential therapeutic target in Toxoplasma and other apicomplexan parasites: some additional thoughts.
Roos DS
Parasitol Today; 1999 Jan; 15(1):41. PubMed ID: 10234180
[No Abstract] [Full Text] [Related]
11. Evaluation of a range of antimicrobial agents against the parasitic protozoa, Plasmodium falciparum, Babesia rodhaini and Theileria parva in vitro.
McColm AA; McHardy N
Ann Trop Med Parasitol; 1984 Aug; 78(4):345-54. PubMed ID: 6206808
[TBL] [Abstract][Full Text] [Related]
12. A double screening trial for the development of drugs against Theileria sergenti in cattle using Babesia rodhaini and Plasmodium berghei in mice.
Ito S; Shimura K
Nihon Juigaku Zasshi; 1985 Feb; 47(1):101-9. PubMed ID: 3884864
[No Abstract] [Full Text] [Related]
13. Carbocyclic frenolicin analogues: novel anticoccidial agents.
Armer RE; Dutton CJ; Fenner BR; Greenwood SD; Hall KT; Rudge AJ
Bioorg Med Chem Lett; 1998 Jan; 8(2):139-42. PubMed ID: 9871641
[TBL] [Abstract][Full Text] [Related]
14. The antitheilerial effects of Theileria parva parva reaction and recovery sera in vitro.
Dolan TT; Stagg DA; Njuguna LM
Int J Parasitol; 1985 Feb; 15(1):43-7. PubMed ID: 3920166
[No Abstract] [Full Text] [Related]
15. Comparison of the antitheilerial effect of Wellcome 993C and halofuginone.
Morgan DW; McHardy N
Res Vet Sci; 1982 Jan; 32(1):84-8. PubMed ID: 6806876
[TBL] [Abstract][Full Text] [Related]
16. Activity of natural and synthetic naphthoquinones against Toxoplasma gondii, in vitro and in murine models of infection.
Ferreira RA; Oliveira AB; Gualberto SA; Vitor RW
Parasite; 2002 Sep; 9(3):261-9. PubMed ID: 12375370
[TBL] [Abstract][Full Text] [Related]
17. Planting new targets for antiparasitic drugs.
Ridley RG
Nat Med; 1998 Aug; 4(8):894-5. PubMed ID: 9701236
[No Abstract] [Full Text] [Related]
18. Infection of the host cells of Theileria annulata with T. parva.
Büscher G; Katende J; Otim B; Morrison WJ
Z Parasitenkd; 1984; 70(5):687-9. PubMed ID: 6438936
[No Abstract] [Full Text] [Related]
19. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
[TBL] [Abstract][Full Text] [Related]
20. The chemotherapy of protozoal infections of veterinary importance.
Joyner LP
J Protozool; 1981 Feb; 28(1):17-9. PubMed ID: 7019418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
